Bavarian Nordic, GSK To Produce Imvamune For Smallpox Vaccine Stockpile
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies will collaborate on manufacturing the modified vaccinia Ankara-Bavarian Nordic vaccine for any future HHS contracts. Under the deal, GSK will also market Imvamune in the Americas, Japan and parts of the EU.